The current landscape of single-port robotic surgery in urology
- PMID: 40897917
- DOI: 10.1038/s41585-025-01081-z
The current landscape of single-port robotic surgery in urology
Abstract
The advent of the purpose-built da Vinci single-port robotic platform marks a pivotal advancement in minimally invasive urological surgery. Designed to overcome the ergonomic and technical limitations of prior single-site approaches, the single-port system enables complex procedures through a single incision, with enhanced dexterity, optimized use of confined spaces and improved cosmetic and peri-operative outcomes. The single-port system has been increasingly used across a wide range of urological indications, including robot-assisted radical prostatectomy, partial nephrectomy, nephroureterectomy and reconstructive surgeries such as pyeloplasty and ureteral re-implantation. Innovative access strategies, such as the single-port transvesical and low anterior access approaches, have facilitated regionalized and multi-quadrant surgeries without the need for repositioning or robot re-docking. These advances have translated into reduced morbidity, faster recovery and increased feasibility of opioid-sparing, same-day discharge protocols. As surgical expertise deepens and technology evolves, the single-port robotic platform stands as a refinement of minimally invasive surgery, and also as a potential paradigm shift in urological practice.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: R.N. is a proctor for Intuitive surgical and a consultant for Fortec medical and Lexion. A. Ghazi has a research grant with Intuitive. A. Mattei is the CEO of Orsi Academy and adviser of Medtronic, Conmed, Microport, Medicaroid, Intuitive and Samantree. M.R. is consultant and proctor for Intuitive. J.S.R. is consultant and proctor for Intuitive. S.R.B. received research funding from Blue Earth Diagnostics and Progenics/Lantheus and is consultant for Intuitive Surgical and GE Healthcare. J.A.L. was a speaker for Intuitive surgical and is on the scientific advisory board of Medtronic. M.S. is on the Intuitive advisory board of VTI. M.A. is a consultant for Intuitive surgical, VTI, Ethicon and BioTissue. R.E.L. is a consultant and proctor for Intuitive. S.C. is a consultant and proctor for Intuitive. J.K. is a consultant for Intuitive, Endoquest, VTI and is on the advisory board of Method AI. R.A. is a consultant and proctor for Intuitive and is on the advisory board of Method AI. The other authors declare no competing interests.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
